Improving timing of antibiotics in neonates with early onset sepsis - Quality improvement project

Cheng Ma1, Garret Levin1,2, Sanjeet K Panda1,2

  • 1Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX, USA.

Insights

Timely antibiotic administration for early onset sepsis (EOS) in newborns was improved through a quality improvement project, reducing infusion time from 70 to 48 minutes. This initiative successfully increased the percentage of neonates receiving antibiotics within one hour of decision-making from 37% to 77%.

Area of Science:

  • Neonatal Medicine
  • Quality Improvement Science
  • Pediatric Infectious Diseases

Background:

  • Early onset sepsis (EOS) significantly contributes to neonatal morbidity and mortality.
  • Prompt antibiotic administration is critical for effective management of neonatal sepsis.
  • A quality improvement project was implemented to enhance the timeliness of antibiotic delivery to neonates.

Purpose of the Study:

  • To reduce the time to antibiotic administration in neonates with suspected early onset sepsis.
  • To improve the overall workflow for antibiotic delivery in a neonatal intensive care unit.

Main Methods:

  • The project focused on optimizing antibiotic delivery from the pharmacy and streamlining electronic medical record (EMR) admission processes.
  • Data on antibiotic administration timings were collected and analyzed using control charts.
  • A Plan-Do-Study-Act (PDSA) methodology was employed, comparing pre-intervention data (December 2016) with post-intervention data (January 2017-November 2018).

Main Results:

  • Significant improvements were observed in the time to EMR admission across PDSA cycles (p < 0.05).
  • Time for antibiotic delivery from pharmacy decreased from 21 to 9 minutes, enhancing workflow efficiency.
  • Average time from decision to antibiotic infusion reduced from 70 to 48 minutes.
  • The proportion of neonates receiving antibiotics within one hour of decision-making increased from 37% to 77%.

Conclusions:

  • The quality improvement project successfully achieved the goal of administering antibiotics within one hour for early onset sepsis.
  • A multidisciplinary approach is key to replicating these improvements in other institutions caring for newborns.
  • Streamlining admission, registration, and EMR entry processes effectively reduced critical time delays.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
156
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
226
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
182
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
677
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
185